Biotechnological production of L-tryptophan
AssigneeTechnische Universitaet Hamburg
InventorsAn-Ping Zeng, Lin Chen
Life of this patent
Estimating the term…
Abstract
A biotechnological production of tryptophan and derivatives thereof, as well as a method for an enhanced microbial L-tryptophan synthesis. In one aspect the invention provides a bacterial cell being genetically modified to express anindole-3-glycerol phosphate synthase, IGPs, the IGPs being less sensitive to inhibition or even being activated by anthranilate compared to the wild type IGPs of the bacterial cell.
Claims6
An Escherichia coli cell being genetically modified to express an indole-3-glycerol phosphate synthase, IGPs, the IGPs being less sensitive to inhibition by anthranilate compared to the wild type IGPs of the Escherichia coli cell, wherein the IGPs has the sequence of one of SEQ ID NO:
- 2, SEQ ID NO:
- 4, SEQ ID NO:
- 5, or SEQ ID NO:
- 30.
An isolated or synthetic enzyme having the sequence of one of SEQ ID NO:
- 2, SEQ ID NO:
- 4, SEQ ID NO:
- 5, and SEQ ID NO:
- 30.
A method for the biotechnological production of L-tryptophan, comprising the steps of
- a) growing a genetically modified Escherichia coli cell, the cell being genetically modified to express an indole-3-glycerol phosphate synthase, IGPs, the IGPs being less sensitive to inhibition by anthranilate compared to the wild type IGPs of the bacterial cell, wherein the IGPs has
- alanine or glycine at position 60 instead of serine, or
- valine at position 8 instead of isoleucine, or
- phenylalanine at position 188 instead of leucine, or
- glutamine at position 58 instead of serine, valine at position 59 instead of proline, phenylalanine at position 60 instead of serine and glutamine at position 61 instead of lysine,
- compared to the sequence of SEQ ID NO:
- 1, in a suitable growth medium in a bioreactor, and separating L-tryptophan from the growth medium, or
- b) growing an Escherichia coli cell being genetically modified to express a heterologous enzyme having IGPs activity, the enzyme being less sensitive to inhibition by anthranilate compared to the wild type IGPs of the Escherichia coli cell, in a suitable growth medium in a bioreactor, and separating L-tryptophan from the growth medium, or
- c) using an enzyme having the sequence of one of SEQ ID NO:
- 2, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, or SEQ ID NO:
- 30, in biosynthesis of L-tryptophan in a suitable medium, and separating L-tryptophan from the medium.
Dependencies are inferred from the claim text.